324 related articles for article (PubMed ID: 27430400)
21. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
22. Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries.
Hernandez I; He M; Brooks MM; Zhang Y
JAMA Netw Open; 2018 Jun; 1(2):e180919. PubMed ID: 30646080
[TBL] [Abstract][Full Text] [Related]
23. Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality.
Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Buizen L; Degenhardt L
Int J Drug Policy; 2024 Jan; 123():104287. PubMed ID: 38088003
[TBL] [Abstract][Full Text] [Related]
24. Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia.
Degenhardt L; Gilmour S; Shand F; Bruno R; Campbell G; Mattick RP; Larance B; Hall W
Drug Alcohol Rev; 2013 Sep; 32(5):468-74. PubMed ID: 23889303
[TBL] [Abstract][Full Text] [Related]
25. Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory rescheduling.
Deacon RM; Nielsen S; Leung S; Rivas G; Cubitt T; Monds LA; Ezard N; Larance B; Lintzeris N
Int J Drug Policy; 2016 Oct; 36():104-11. PubMed ID: 27453147
[TBL] [Abstract][Full Text] [Related]
26. Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients.
Sankey C; Setnik B; Harsanyi Z; Michalko K; Yang Z; Geoffroy P
J Opioid Manag; 2016; 12(2):149-59. PubMed ID: 27194200
[TBL] [Abstract][Full Text] [Related]
27. Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder.
Struble CA; Thomas K; Stenersen MR; Moore KE; Burke C; Pittman B; McKee SA
Am J Addict; 2022 May; 31(3):200-209. PubMed ID: 35243706
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically.
Bouvier BA; Waye KM; Elston B; Hadland SE; Green TC; Marshall BDL
Drug Alcohol Depend; 2018 Feb; 183():73-77. PubMed ID: 29241103
[TBL] [Abstract][Full Text] [Related]
29. Drug Overdose in a Retrospective Cohort with Non-Cancer Pain Treated with Opioids, Antidepressants, and/or Sedative-Hypnotics: Interactions with Mental Health Disorders.
Turner BJ; Liang Y
J Gen Intern Med; 2015 Aug; 30(8):1081-96. PubMed ID: 25650263
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and Trends of Concurrent Opioid Analgesic and Benzodiazepine Use Among Veterans Affairs Patients with Post-traumatic Stress Disorder, 2003-2011.
Hawkins EJ; Malte CA; Grossbard JR; Saxon AJ
Pain Med; 2015 Oct; 16(10):1943-54. PubMed ID: 26332513
[TBL] [Abstract][Full Text] [Related]
31. Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Nielsen S; Bruno R; Degenhardt L; Demirkol A; Lintzeris N
Drug Alcohol Rev; 2017 May; 36(3):311-316. PubMed ID: 27273511
[TBL] [Abstract][Full Text] [Related]
32. Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018.
Borrelli EP; Bratberg J; Hallowell BD; Greaney ML; Kogut SJ
J Manag Care Spec Pharm; 2022 Jan; 28(1):58-68. PubMed ID: 34949119
[No Abstract] [Full Text] [Related]
33. Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates.
Chan GCK; Leung J; Hall W
Drug Alcohol Rev; 2019 Feb; 38(2):151-158. PubMed ID: 30652366
[TBL] [Abstract][Full Text] [Related]
34. Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory.
McClure FL; Niles JK; Kaufman HW; Gudin J
J Addict Med; 2017; 11(6):420-426. PubMed ID: 28953504
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of a Retrospective Drug Utilization Review on Potentially Unsafe Opioid and Central Nervous System Combination Therapy.
Qureshi N; Wesolowicz LA; Liu CM; Tungol Lin A
J Manag Care Spec Pharm; 2015 Oct; 21(10):938-44. PubMed ID: 26402392
[TBL] [Abstract][Full Text] [Related]
36. An electronic intervention to improve safety for pain patients co-prescribed chronic opioids and benzodiazepines.
Zaman T; Rife TL; Batki SL; Pennington DL
Subst Abus; 2018; 39(4):441-448. PubMed ID: 29595408
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for concurrent use of benzodiazepines and opioids among individuals under community corrections supervision.
Cropsey KL; Stevens EN; Valera P; Brendan Clark C; Bulls HW; Nair P; Lane PS
Drug Alcohol Depend; 2015 Sep; 154():152-7. PubMed ID: 26208793
[TBL] [Abstract][Full Text] [Related]
38. The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids.
Nielsen S; Bruno R; Degenhardt L; Stoove MA; Fischer JA; Carruthers SJ; Lintzeris N
Med J Aust; 2013 Nov; 199(10):696-9. PubMed ID: 24237102
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and characteristics of patients prescribed opioids and central nervous system depression agents on discharge to hospice care.
Nguyen CT; McPherson ML; Noble BN; Furuno JP
Ann Palliat Med; 2024 Mar; 13(2):240-248. PubMed ID: 38462934
[TBL] [Abstract][Full Text] [Related]
40. Risk of Overdose with Exposure to Prescription Opioids, Benzodiazepines, and Non-benzodiazepine Sedative-Hypnotics in Adults: a Retrospective Cohort Study.
Cho J; Spence MM; Niu F; Hui RL; Gray P; Steinberg S
J Gen Intern Med; 2020 Mar; 35(3):696-703. PubMed ID: 31919729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
